© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
July/August 2014
Opsumit by Actelion Pharmaceuticals US, Inc
August 21, 2014
Article
New Drug Review
Opsumit (macitentan) was approved to reduce the risk of hospitalization and delay disease progression in patients with WHO group I pulmonary arterial hypertension.
Multiple Myeloma Precursor More Common Among Black Patients
August 20, 2014
Article
Disease State Management
Direct-Acting Antiviral Combination Therapies Can Become Novel Therapeutic Standard in HCV Treatment
August 20, 2014
Article
Disease State Management
Female Intravenous Drug Users Have Higher Rates of HCV Infection Due to Riskier Habits
August 20, 2014
Article
Disease State Management
Increased BMI Increases Multiple Myeloma Mortality Risk
August 20, 2014
Article
Disease State Management
New Biopsy Method More Effective in Revealing Aggressive Prostate Cancer
August 20, 2014
Article
Disease State Management
Insulin Therapy Tied to Increased Death Risk for Multiple Myeloma Patients
August 20, 2014
Article
Disease State Management
Study Finds Link Between Chronic Inflammation and High-Grade Prostate Cancer
August 20, 2014
Article
Disease State Management
Sonographic Evaluation of Liver Elasticity Shows Promise in Predicting Post Liver Transplant HCV Recurrence
August 20, 2014
Article
Disease State Management
Chemotherapy Treatment Extends Survival More than a Year in New Prostate Cancer Patients
August 20, 2014
Article
Disease State Management
Managing Hepatitis C Costs, Improving Patient Outcomes
August 20, 2014
Article
Clinical Insights
New drugs to treat hepatitis C herald a new era of higher cure rates, but with these new treatment options comes an increased need for patient support and adherence counseling.
Psoriatric Arthritis: An Overview
August 20, 2014
Article
Clinical Insights
Early diagnosis is the key to successful management of psoriatic arthritis, and treatment of this inflammatory disease is largely dependent on which symptoms are predominant.
Evaluating and Elevating Specialty Pharmacists Through Certification
August 20, 2014
Article
Features
The development of the Certified Specialty Pharmacist provides the opportunity for specialty pharmacists to demonstrate their expertise through an evaluation of their skills.
Keeping an Eye on Hepatitis C Virus Drug Approvals
August 20, 2014
Article
Features
With the recent approval of new hepatitis C treatments, payers are increasingly concerned with controlling costs in this category through policies that may affect treatment decisions.
Specialty Pharmacy in Retail: A Face-to-Face Patient Experience
August 20, 2014
Article
Features
Community-based specialty pharmacies are poised to set the trend for delivery of specialty drugs because of their emphasis on the personal care and patient management that help ensure positive outcomes.
Specialty Pipeline Highlights
August 19, 2014
Article
New Product Pipeline
Approval is expected in 2014 for drugs to treat psoriasis, cancer, and orphan conditions.
How Will Specialty Pharmacy Be Affected By Cost Containment?
August 19, 2014
Article
Viewpoints: The Last Word
Cost containment and formulary management policies can have a major effect on the ways in which specialty pharmacists provide services to patients.
Community Specialty Pharmacy: The Time Is Now!
August 19, 2014
Article
Features
When specialty pharmacists refine their skills and adapt their methods of providing services to patients, they are directing their own destinies and taking on a valuable role in the community.
Bullied into Extinction
August 19, 2014
Article
Specialty Speaks
Government involvement may be required in order to keep corporate entities from bullying specialty pharmacies out of business.
Specialty Is Not Always Pharmacy: Uncovered Secrets
August 19, 2014
Article
Editorial
Many specialty products require a limited access approach, and specialty pharmacists need to have knowledge of the distribution and supply chain structure.